Skip Navigation

Annals of Oncology 2009 20(1):3-4; doi:10.1093/annonc/mdn780
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Baselga, J.
Right arrow Articles by Kerr, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Baselga, J.
Right arrow Articles by Kerr, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

editorial

ESMO's new strategic plan: our society's road to the future of oncology

J. Baselga, H. Mellsted and D. Kerr

on behalf of ESMO

The first 10% of the full text of this article appears below.

After 30 years of continued growth and progress, the European Society for Medical Oncology (ESMO) through its Executive Committee recently agreed on the need to launch a major strategic plan that would carefully analyze the current status of oncology and the needs of our members and that would assist us in selecting our priorities on multiple fronts in years to come. This strategic plan has now been completed and approved by our Society's General Assembly and is in the process of being implemented by our office as well by an army of members and volunteers.

The first sobering realization at age 30 of our society is that despite apparent advances in several fronts from basic research to improved therapies, cancer continues to be a major cause of suffering and death in our population. In Europe . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Ann OncolHome page
J. B. Vermorken
Annals of Oncology: some modest proposals but some great aims
Ann. Onc., August 1, 2009; 20(8): 1289 - 1290.
[Full Text] [PDF]